BiomEdit
Fishers, US · Founded 2022 · Delaware corporation · 5 known investors
Find your way into BiomEdit
471 people in our graph share verified history with the BiomEdit team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Aaron Schacht · together at University of Illinois Urbana-Champaign (overlapped)
×4knows the team · via University of Illinois Urbana-Champaign
×3knows the team · via ABB
×3knows the team · via SDA Bocconi
knows the team · via Elanco
BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms. The company applies synthetic biology techniques to modify microbial populations for therapeutic and agricultural applications.
Founders & leadership
BS
Bruce SchelkopfinChief Legal Officer (CLO) & Chief Administrative Officer (CAO), GC, Company Secretary, CIPO/COO/CCOBruce Schelkopf serves as Executive Officer at BiomEdit. He brings experience in global legal operations, intellectual property strategy, regulatory compliance, and business development across technology and pharmaceutical sectors.
AS
Aaron SchachtinChief Executive Officer and Board DirectorAaron Schacht has over 35 years of experience in life sciences and serves as CEO of BiomEdit. He previously held executive leadership roles at Elanco Animal Health, where he was involved in business development and M&A activities, and has been involved in founding and funding multiple venture-backed companies in the biotechnology sector.
Board
PJ
Patrick JamesBoard director
PC
Paul CasadyBoard director
BW
BB
Barbara BodemBoard director
Investors · 5
AgriZeroNZreported · 2 sources
Anterra Capitalreported · 3 sourcesAmsterdam · $20M
Elevate Venturesreported · 2 sourcesIndianapolis · $20K – $2M
Also in the syndicate · 2
Betagro VenturesNutreco
Funding
SEC filings, press & company announcements$16M disclosed across 1 of 2 rounds · 2025–2026
- Undisclosed amountseries BFeb 2026Source ↗
▶$16MraisedJun 2025 · 17 investors · BiotechnologyRule 506(b)
▶$16MraisedJun 2025 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce SchelkopfExecutive Officer
- Patrick JamesDirector
- Paul CasadyDirector
- Brett WongDirector
- Aaron SchachtExecutive Officer, Director
- Barbara BodemDirector
- Offering amount
- $20M
- Amount sold
- $16M
- Minimum investment
- $25K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IQVIA5 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
bio5 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Viome4 shared keywordsViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
Companies competing with BiomEdit for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does BiomEdit do?
- BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms. The company applies synthetic biology techniques to modify microbial populations for therapeutic and agricultural applications.
- Who are BiomEdit's investors?
- BiomEdit's investors include AgriZeroNZ, Anterra Capital, Elevate Ventures.
- How much funding has BiomEdit raised?
- BiomEdit has disclosed $16M raised across 1 of its 2 known rounds.
- Where is BiomEdit headquartered?
- BiomEdit is headquartered in Fishers, US.